
Doctor Inna Thalmann
University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
Membership:
ESC Professional Member
Biography
Inna is a Postdoctoral Fellow at the Clinical Trial Service Unit (CTSU), Nuffield Department of Population Health, University of Oxford. Her research focusses on the development of novel multi-source-based phenotype algorithms for health and safety outcomes ascertainment in routine health data. Prior to this, Inna completed her PhD in Health Economics at the Health Economics Research Centre (HERC), University of Oxford. Her doctoral research investigated the trends and determinants of medication use for the secondary prevention of cardiovascular disease in the UK, using NHS Scotland data. The research was funded by a Medical Research Council UK (MRC) and Nuffield Department of Population Health (NDPH) scholarship, and a British Heart Foundation Centre of Research Excellence (BHF CRE) Pump Priming grant.
Contributor content
Presentation
Antiplatelet therapy use for the secondary prevention of cardiovascular disease in 2009-2017: a population-wide retrospective cohort study of Scotland
Presentation

